Just playing with some of the figures from today's presentation.
In the benchmark study 41% of patients fully healed.
In our current one it's currently 53%.
If we assume in our study that the placebo's third is similar to the benchmark study, then the two thirds on our drug have a full healing rate of 60%.
60% compared to 41% is nearly a 50% improvement over the benchmark, which is a hugely statistically significant benefit.
ok, there is the assumption that the placebo mirrors the benchmark result - but that's all we have to go on at the moment.
Cheers
- Forums
- ASX - By Stock
- run coming?
Just playing with some of the figures from today's presentation....
-
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online